Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Embecta Corp EMBC

Healthcare Medical Instruments & Supplies
Embecta Corp. is a global diabetes care company. It is focused on providing solutions to people living with diabetes. It has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, designed to be used in conjunction with... see more

Recent & Breaking News (NDAQ:EMBC)

Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs

GlobeNewswire 2 days ago

embecta Announces Quarterly Cash Dividend

GlobeNewswire 2 days ago

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire November 12, 2024

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire November 12, 2024

embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell

GlobeNewswire November 7, 2024

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

GlobeNewswire September 3, 2024

embecta to Participate in Investor Events

GlobeNewswire August 22, 2024

Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results

GlobeNewswire August 9, 2024

embecta Announces Quarterly Cash Dividend

GlobeNewswire August 9, 2024

Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company

PR Newswire July 29, 2024

embecta to Report Fiscal Third Quarter 2024 Financial Results

GlobeNewswire July 18, 2024

embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir

GlobeNewswire June 24, 2024

Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results

GlobeNewswire May 9, 2024

embecta Announces Quarterly Cash Dividend

GlobeNewswire May 9, 2024

embecta to Participate in Investor Events

GlobeNewswire May 1, 2024

embecta to Report Fiscal Second Quarter 2024 Financial Results

GlobeNewswire April 23, 2024

embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes

GlobeNewswire March 6, 2024

Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results

GlobeNewswire February 9, 2024

embecta Announces Quarterly Cash Dividend

GlobeNewswire February 9, 2024

embecta to Participate in the 11th Annual BTIG MedTech Conference

GlobeNewswire February 7, 2024